These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2647398

  • 21. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia.
    Browne J, Silver H, Martin R, Hart R, Mergener M, Williams P.
    J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    McGrath JJ, Soares KV.
    Cochrane Database Syst Rev; 2000 Apr; (2):CD000207. PubMed ID: 10796324
    [Abstract] [Full Text] [Related]

  • 24. Cytidine diphosphate choline improves the outcome of cardiac arrest vs epinephrine in rat model.
    Yu H, Qing H, Lei Z.
    Am J Emerg Med; 2013 Jul; 31(7):1022-8. PubMed ID: 23688565
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. CDP-choline as a drug for pancreatitis.
    Hashihira S, Nishii T, Mori R, Takeda Y, Tai J.
    Bull Osaka Med Sch; 1974 Jul; 20(1):19-25. PubMed ID: 4457204
    [No Abstract] [Full Text] [Related]

  • 28. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV, Wyatt RJ.
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N, Marsden CD.
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [Abstract] [Full Text] [Related]

  • 34. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
    Tammenmaa IA, Sailas E, McGrath JJ, Soares-Weiser K, Wahlbeck K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A, Villeneuve A, Gautier J, Jus K, Villeneuve C, Pires P, Villeneuve R.
    Neuropsychobiology; 1978 Nov; 4(3):140-9. PubMed ID: 340975
    [Abstract] [Full Text] [Related]

  • 40. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
    de Montigny C, Chouinard G, Annable L.
    Psychopharmacology (Berl); 1979 Nov; 65(3):219-23. PubMed ID: 117492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.